Stock listing
NASDAQ:EDIT Editas Medicine, Inc. Stock
Home listing (NASDAQ) of Editas Medicine, Inc.
Follow Editas Medicine, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:EDIT
$2.67 USD -0.26 (-8.9%)
Close on Oct 30, 2026
- Day range
- $2.60 – $2.92 USDOct 30, 2026
- Volume
- 2.91M sharesOct 30, 2026
- Market cap
- $410.1M USDAt the close on Oct 30, 2026 · price × 153.6M shares outstanding
- 52-week range
- $1.66 – $3.94 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $7.41M USDMedian day 2.18M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:EDIT · Home | $2.67 USD | -0.26 (-8.9%) | 2,908,802 | $2.89 | $2.92 | $2.60 | $2.93 | Close on Oct 30, 2026 |
| LSE:0IFK | $2.57 USD | +0.205 (+8.7%) | 16,821 | $2.40 | $2.592 | $2.40 | $2.365 | Close on Oct 27, 2026 |
| Frankfurt:8EM | €2.54 EUR | +0.44 (+21.0%) | — | €2.54 | €2.54 | €2.54 | €2.10 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:EDIT · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.67 | -0.26 | -8.9% | $2.89 | $2.92 | $2.60 | 2,908,802 | |
| $2.93 | -0.02 | -0.7% | $2.945 | $2.98 | $2.86 | 3,224,947 | |
| $2.95 | +0.35 | +13.5% | $2.59 | $2.96 | $2.54 | 4,407,190 | |
| $2.60 | +0.20 | +8.3% | $2.41 | $2.61 | $2.371 | 3,078,317 | |
| $2.40 | 0.00 | 0.0% | $2.39 | $2.445 | $2.36 | 1,350,754 | |
| $2.40 | -0.09 | -3.6% | $2.44 | $2.45 | $2.30 | 1,313,712 | |
| $2.49 | -0.02 | -0.8% | $2.47 | $2.58 | $2.45 | 1,066,486 | |
| $2.51 | -0.07 | -2.7% | $2.59 | $2.60 | $2.50 | 1,139,426 | |
| $2.58 | +0.16 | +6.6% | $2.40 | $2.665 | $2.35 | 2,266,488 | |
| $2.42 | +0.07 | +3.0% | $2.38 | $2.43 | $2.27 | 2,010,947 | |
| $2.35 | -0.09 | -3.7% | $2.44 | $2.47 | $2.33 | 1,551,300 | |
| $2.44 | +0.17 | +7.5% | $2.26 | $2.465 | $2.25 | 1,858,600 | |
| $2.27 | -0.175 | -7.2% | $2.44 | $2.475 | $2.245 | 2,827,200 | |
| $2.445 | -0.305 | -11.1% | $2.73 | $2.73 | $2.44 | 2,449,700 | |
| $2.75 | -0.15 | -5.2% | $2.90 | $2.91 | $2.73 | 1,296,400 | |
| $2.90 | +0.06 | +2.1% | $2.85 | $2.97 | $2.71 | 3,087,100 | |
| $2.84 | +0.09 | +3.3% | $2.79 | $2.945 | $2.69 | 6,067,000 | |
| $2.75 | +0.02 | +0.7% | $2.71 | $2.845 | $2.659 | 2,264,700 | |
| $2.73 | -0.06 | -2.2% | $2.85 | $2.895 | $2.715 | 2,967,500 | |
| $2.79 | +0.17 | +6.5% | $2.62 | $2.81 | $2.555 | 3,012,000 | |
| $2.62 | +0.10 | +4.0% | $2.57 | $2.63 | $2.51 | 2,162,800 | |
| $2.52 | -0.05 | -1.9% | $2.61 | $2.62 | $2.52 | 1,544,200 | |
| $2.57 | -0.02 | -0.8% | $2.61 | $2.72 | $2.55 | 1,624,500 | |
| $2.59 | +0.08 | +3.2% | $2.54 | $2.62 | $2.51 | 1,568,500 | |
| $2.51 | -0.07 | -2.7% | $2.55 | $2.55 | $2.42 | 2,203,200 | |
| $2.58 | -0.17 | -6.2% | $2.76 | $2.78 | $2.57 | 3,117,600 | |
| $2.75 | +0.06 | +2.2% | $2.66 | $2.76 | $2.545 | 2,589,800 | |
| $2.69 | -0.23 | -7.9% | $3.12 | $3.14 | $2.67 | 5,161,700 | |
| $2.92 | +0.09 | +3.2% | $2.86 | $2.93 | $2.805 | 2,293,900 | |
| $2.83 | +0.13 | +4.8% | $2.76 | $2.89 | $2.695 | 2,489,000 | |
| $2.70 | -0.02 | -0.7% | $2.73 | $2.825 | $2.68 | 17,028,800 | |
| $2.72 | +0.01 | +0.4% | $2.80 | $2.945 | $2.71 | 3,512,900 | |
| $2.71 | +0.08 | +3.0% | $2.65 | $2.73 | $2.63 | 2,493,500 | |
| $2.63 | -0.11 | -4.0% | $2.70 | $2.71 | $2.59 | 1,680,500 | |
| $2.74 | +0.04 | +1.5% | $2.72 | $2.815 | $2.66 | 1,687,100 | |
| $2.70 | +0.05 | +1.9% | $2.68 | $2.72 | $2.62 | 2,463,600 | |
| $2.65 | -0.12 | -4.3% | $2.77 | $2.77 | $2.62 | 2,543,400 | |
| $2.77 | -0.26 | -8.6% | $3.06 | $3.06 | $2.77 | 2,963,000 | |
| $3.03 | -0.20 | -6.2% | $3.20 | $3.215 | $3.01 | 2,275,700 | |
| $3.23 | +0.15 | +4.9% | $3.04 | $3.23 | $3.04 | 1,390,400 | |
| $3.08 | 0.00 | 0.0% | $3.09 | $3.13 | $3.00 | 1,378,100 | |
| $3.08 | +0.01 | +0.3% | $3.09 | $3.23 | $2.98 | 1,678,500 | |
| $3.07 | +0.01 | +0.3% | $3.00 | $3.155 | $2.98 | 1,225,200 | |
| $3.06 | -0.10 | -3.2% | $3.12 | $3.14 | $3.025 | 2,075,700 | |
| $3.16 | -0.14 | -4.2% | $3.25 | $3.41 | $3.15 | 3,270,100 | |
| $3.30 | +0.12 | +3.8% | $3.17 | $3.37 | $3.15 | 2,665,000 | |
| $3.18 | -0.10 | -3.0% | $3.40 | $3.515 | $3.16 | 2,944,000 | |
| $3.28 | +0.28 | +9.3% | $3.05 | $3.33 | $3.05 | 4,212,991 | |
| $3.00 | -0.11 | -3.5% | $3.14 | $3.18 | $2.97 | 2,062,340 | |
| $3.11 | +0.17 | +5.8% | $2.98 | $3.245 | $2.95 | 2,109,000 | |
| $2.94 | -0.31 | -9.5% | $3.17 | $3.229 | $2.92 | 4,262,300 | |
| $3.25 | +0.37 | +12.8% | $3.01 | $3.30 | $2.99 | 9,641,300 | |
| $2.88 | +0.04 | +1.4% | $2.89 | $2.99 | $2.80 | 2,232,600 | |
| $2.84 | +0.02 | +0.7% | $2.80 | $2.895 | $2.77 | 2,113,700 | |
| $2.82 | +0.01 | +0.4% | $2.81 | $2.845 | $2.715 | 1,478,000 | |
| $2.81 | -0.03 | -1.1% | $2.85 | $2.90 | $2.81 | 1,272,400 | |
| $2.84 | -0.11 | -3.7% | $2.96 | $3.025 | $2.82 | 1,629,900 | |
| $2.95 | +0.14 | +5.0% | $2.84 | $2.99 | $2.83 | 1,910,800 | |
| $2.81 | -0.07 | -2.4% | $2.84 | $2.90 | $2.79 | 1,464,800 | |
| $2.88 | -0.02 | -0.7% | $2.99 | $3.09 | $2.87 | 1,692,900 | |
| $2.90 | +0.15 | +5.5% | $2.82 | $3.14 | $2.81 | 3,429,400 | |
| $2.75 | -0.02 | -0.7% | $2.79 | $2.87 | $2.745 | 1,938,300 | |
| $2.77 | +0.12 | +4.5% | $2.69 | $2.78 | $2.64 | 1,559,400 | |
| $2.65 | +0.07 | +2.7% | $2.60 | $2.65 | $2.53 | 775,100 | |
| $2.58 | -0.11 | -4.1% | $2.67 | $2.703 | $2.53 | 1,180,800 | |
| $2.69 | +0.09 | +3.5% | $2.60 | $2.705 | $2.60 | 834,000 |
- Ticker
- NASDAQ:EDIT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 14, 2026
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Latest deck · June 2026
Investor Presentation (June 2026)
Investor deck · 17 slides
Calls
Replays
Editas Medicine (NASDAQ:EDIT) Q2 2024 Earnings Call
Wed, Aug 07, 2024 · 8:00 AM ET
Watch TranscriptEditas Medicine (NASDAQ:EDIT) Q1 2024 Earnings Call
Wed, May 08, 2024 · 8:00 AM ET
Watch TranscriptEditas Medicine (NASDAQ:EDIT) Q4 2023 Earnings Call
Wed, Feb 28, 2024 · 8:00 AM ET
Watch Transcript
Latest news
Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference
Oct 14, 2026
Closed $2.27 (-7.2%) on Oct 14, 2026
Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia
Oct 8, 2026
Closed $2.84 (+3.3%) on Oct 8, 2026
Editas Medicine Appoints Dan Ory, M.D., as Chief Medical Officer
Sep 8, 2026
Closed $3.03 (-6.2%) on Sep 8, 2026
Editas Medicine Announces Second Quarter 2026 Results and Business Updates
Aug 5, 2026
Closed $2.90 (+5.5%) on Aug 6, 2026
Editas Medicine Strengthens Board of Directors with Appointment of Patrick T. Ellinor, M.D., Ph.D.
Aug 4, 2026
Closed $2.75 (-0.7%) on Aug 5, 2026
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May 28, 2026
Closed $3.46 (+0.9%) on May 29, 2026
Editas Medicine Announces Proposed Public Offering
May 26, 2026
Closed $3.08 (+11.6%) on May 26, 2026
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
May 26, 2026
Closed $3.08 (+11.6%) on May 26, 2026
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
May 14, 2026
Closed $2.85 (-1.7%) on May 14, 2026
Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 5, 2026
Closed $3.04 (+1.3%) on May 5, 2026
Decks
Investor Presentation (June 2026)
Investor deck · 17 slides · June 2026
TIDES 2026
Conference · 20 slides · May 14, 2026
ASGCT 29th Annual Meeting 2026
Conference · 20 slides · May 2026
ASGCT 28th Annual Meeting 2025
Conference · 8 slides · May 2025
Editas Medicine, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 187 in all · newest Oct 14, 2026 · oldest 2019
- Calls
- 16 calls with a replay · 16 with a transcript · latest Aug 7, 2024
- Decks
- 25 decks · latest June 2026
Where Editas Medicine, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:EDIT · Home listing · This page | NASDAQ | United States | USD |
| gettex:8EM | gettex | Germany | EUR |
| BOATS:EDIT | BOATS | United States | USD |
| Tradegate:8EM | Tradegate | Germany | EUR |
| LS Exchange:A2AC4K | LS Exchange | Germany | EUR |
| Stuttgart:8EM | Stuttgart | Germany | EUR |
| Lang & Schwarz:A2AC4K | Lang & Schwarz | Germany | EUR |
| LSE:0IFK | LSE | United Kingdom | USD |
| Frankfurt:8EM | Frankfurt | Germany | EUR |
| BX Swiss:8EM | BX Swiss | Switzerland | CHF |
| Dusseldorf:8EM | Dusseldorf | Germany | EUR |
| Hamburg:8EM | Hamburg | Germany | EUR |
| Munich:8EM | Munich | Germany | EUR |
Log in to ask 6ix AI your own questions about Editas Medicine, Inc.